Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

WuXi AppTec Raises $1.5 Billion From Ping An for China Healthcare

publication date: Mar 1, 2016
WuXi AppTec, China's largest CRO/CMO, secured a five-year $1.5 billion line of credit from Ping An Bank, a subsidiary of the China insurance company. Details of the agreement were not disclosed, but the agreement apparently includes some form of partnership. The primary goal seems to be healthcare, centered on six major cities including Shanghai. Ping An is no stranger to WuXi: it was one of the investors in WuXi's $3.3 billion privatization last year. Reports recently surfaced that WuXi in planning to IPO its biologics R&D and manufacturing businesses in a Hong Kong IPO that values the division at $1.5 billion. Now, the Ping An news shows that WuXi's financial engineering is continuing. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here